Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Comment by bilosellhion May 29, 2003 7:44pm
523 Views
Post# 6128087

RE: We have an ONC insider

RE: We have an ONC insider interesting observation... lets see now... we have many people observing that BT was rather tight-lipped with his AGM presentation. having listened to it myself, if he fails at making onc successful, i think he has a future in producing 28.8K internet recordings to help people fall asleep. yet we also have the "revelation" that an onc "insider" has been posting on this board for some time, apparently stating with authority things that the president of the company won't even commment publicly on, presumably for confidentiality reasons. that Calgary Herald article about market regulators looking into unusal trading in onc is starting to make more sense. maybe the authorization for the issuance of an additional 11M shares was done to ensure they could raise enough money to continue for another 12 months (remember this was proposed when onc was still at $1.50) rather than issuing to a potential partner? based on all the heightened speculation and hype that has turned into expectation here about an "imminent" partnership, if onc doesn't come through "soon" as some put it, we'll be back in the $2's, if not lower, in no time. something to think about.
Bullboard Posts